ADAPTIVE BIOTECHNOLOGIES
ADPT · NASDAQ
Updated at 2026-10-14 08:28:06
- Today's High
- $25.86
- Today’s Low
- $24.66
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $26.31
- Previous Close
- $25.57
- Volume
- 3.12M
- Market Cap
- $4.08B
- P/E Ratio
- --
- EPS
- $-0.40
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Life Sciences Tools & Services
- Sub-industry
- DIAGNOSTICS & RESEARCH
- Headquarters
- 1165 EASTLAKE AVENUE EAST, SEATTLE, WA, UNITED STATES, 98109
- Country
- US
- Listing Date
- 2019-06-27
- Fiscal Year End
- December
- Shares Outstanding
- 159.06M
- CIK
- 0001478320
- Website
- www.adaptivebiotech.com
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company is headquartered in Seattle, Washington.
Financial Metrics
Revenue
2026-06-30
$71.55M
2026-03-31
$70.87M
2025-12-31
$71.68M
2025-09-30
$93.97M
Operating Expenses
2026-06-30
$66.73M
2026-03-31
$71.37M
2025-12-31
$66.23M
2025-09-30
$65.52M
Net Income
2026-06-30
-$39.78M
2026-03-31
-$20.03M
2025-12-31
-$13.57M
2025-09-30
$9.54M
Net Profit Margin
2026-06-30
-55.6%
2026-03-31
-28.26%
2025-12-31
-18.94%
2025-09-30
10.15%
Earnings Per Share
2026-06-30
$-0.10
2026-03-31
$-0.13
2025-12-31
$-0.09
2025-09-30
$-0.15
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$12.07M
2026-03-31
-$14.37M
2025-12-31
-$6.43M
2025-09-30
$16.92M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $71.55M | $70.87M | $71.68M | $93.97M |
| Operating Expenses | $66.73M | $71.37M | $66.23M | $65.52M |
| Net Income | -$39.78M | -$20.03M | -$13.57M | $9.54M |
| Net Profit Margin | -55.6% | -28.26% | -18.94% | 10.15% |
| Earnings Per Share | $-0.10 | $-0.13 | $-0.09 | $-0.15 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$12.07M | -$14.37M | -$6.43M | $16.92M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.